Nebivolol
Back to searchMolecule Structure
Scientific Name
Nebivolol
Description of the Drug
Nebivolol is a beta blocking agent used to treat hypertension and aid in the management of heart failure.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB04861
http://www.drugbank.ca/drugs/DB04861
Brand Name(s)
Hypoloc, Nebilet
Company Owner(s)
Indchemie Health Specialties Pvt Ltd, Ajanta Pharma Ltd, Alkem Laboratories Ltd, Watson Laboratories Inc, Reyoung Corporation, Hetero Labs Ltd Unit Iii, Aurobindo Pharma Ltd, Ani Pharmaceuticals Inc, Glenmark Pharmaceuticals Ltd, Unichem Laboratories Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Beta-1 adrenergic receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL213 |
| Beta-2 adrenergic receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL210 |
Clinical Trial(s)
Unichem Links
| Atlas | nebivolol | ||
| SureChEMBL | SCHEMBL19863 | ||
| PharmGKB | PA151958426 | ||
| Human Metabolome Database | HMDB0015594 | ||
| DrugBank | DB04861 | ||
| PubChem: Thomson Pharma | 14757350 | ||
| PubChem | 71301 | ||
| LINCS | LSM-46208 | ||
| Nikkaji | J33.390E | ||
| BindingDB | 84735 | ||
| EPA CompTox Dashboard | DTXSID9040556 | ||
| DrugCentral | 1887 | ||
| Guide to Pharmacology | 7246 | ||
| rxnorm | NEBIVOLOL | BYSTOLIC | NEBIVOLOL HYDROCHLORIDE |
| ChEBI | 64019 |
